Screening Biochemical Markers for the Prevention of Coronary Heart Disease

Chapter

Abstract

Coronary heart disease (CHD) is among one of the major causes of deaths in Mauritius. It is important to screen biochemical markers, amongst other clinical and para-clinical tests, in view of the prevention of the disease. The study consisted of screening a random sample of 300 employees for total cholesterol above the desirable range (>5.17 mmol/l). A second fasting blood test was performed in those who had high total cholesterol. The lipid profile was performed using commercially available kits. The Total Cholesterol to High Density Lipoprotein Cholesterol ratio was calculated for identification of those at risk of CHD.

The findings showed an important prevalence of blood lipid abnormalities in the studied population, thus highlighting the need for screening for abnormal levels of these biochemical markers.

Keywords

Coronary Heart Disease Coronary Heart Disease Risk Coronary Heart Disease Risk Factor Workplace Setting Fast Blood Sugar Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

The authors are thankful to the staff of the Department of Medicine, University of Mauritius for technical support provided.

References

  1. 1.
    World Health Organization (2004) Global burden of coronary heart disease. In: Mackay J, Mensah G (eds) The atlas of heart disease and stroke, Part 3: the burden. World Health Organization, Geneva. http://www.who.int/cardiovascular_diseases/resources/atlas/en/. Accessed 8 Sept 2010
  2. 2.
    World Health Organization (2005) Preventing chronic diseases: a vital investment. World Health Organization, Geneva. http://www.who.int/. Accessed 8 Sept 2010
  3. 3.
    Brewer HB (2004) A new dawn in the treatment of Dyslipidaemia: cardiovascular risk reduction through emerging science and proven clinical results. Am Heart J 148:S1–S2CrossRefGoogle Scholar
  4. 4.
    Gupta R, Gupta HP, Kumar N, Joshi AK, Gupta VP (1994) Lipoprotein lipids and the prevalence of hyperlipidaemia in rural India. J Cardiovasc Risk 1:179–184Google Scholar
  5. 5.
    Rafiei M, Boshtam M, Sarraf-Zadegan N (1999) Lipid profiles in the Isfahan population: an Isfahan cardiovascular disease risk factor survey, 1994. East Mediterr Health J 5:766–777Google Scholar
  6. 6.
    Foucan L, Kangambega P, Koumavi Ekouevi D, Rozet JE, Bangou-Brédent J (2000) Lipid profile in an adult population in Guadeloupe. Diabetes Metab 26:473–480Google Scholar
  7. 7.
    Yarzebski J, Spencer F, Goldberg RJ, Lessard D, Gore JM (2001) Temporal trends (1986–1997) in cholesterol level assessment and management practices in patients with acute myocardial infarction. Arch Intern Med 161:1521–1528CrossRefGoogle Scholar
  8. 8.
    Wang TD, Chen WJ, Chien KL, Su SS, Hsu HC, Chen MF, Liau CS, Lee YT (2001) Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a chinese population. Am J Cardiol 88:737–743CrossRefGoogle Scholar
  9. 9.
    American Association of Clinical Endocrinologist (AACE) (2002) AACE lipid guidelines. Endocr Pract 6:4–52Google Scholar
  10. 10.
    Eghan BA Jr, Acheampong JW (2003) Dyslipidaemia in outpatients at General Hospital in Kumasi, Ghana: cross-sectional study. Croat Med J 44:576–578Google Scholar
  11. 11.
    National Cholesterol Education Program Expert Panel (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high cholesterol in adults (Adults Treatment Panel III). J Am Med Assoc 285:2486–2497CrossRefGoogle Scholar
  12. 12.
    Rifai N, Bachorik PS, Albers JJ (1999) Lipids, lipoproteins & apolipoproteins. In: Burtis CA, Ashwood ER (eds) Tietz textbook of clinical chemistry, 3rd edn. Saunders, Philadelphia, pp 809–861Google Scholar
  13. 13.
    World Health Organization (2010) Health systems financing: the path to universal coverage. The world health report 2010. World Health Organization, Geneva. http://www.who.int/whr/2010/en/index.html. Accessed 8 Sept 2010
  14. 14.
    Ministry of Health and Quality of Life, Republic of Mauritius (2009) The trends in diabetes and cardiovascular disease risk in Mauritius. Mauritius non communicable diseases survey reportGoogle Scholar
  15. 15.
    United States Preventive Services Task Force (2008) Screening for lipid disorders in adults: recommendation statement. http://www.uspreventiveservicestaskforce.org/uspstf08/lipid/lipidrs.htm. Accessed 8 Sept 2010
  16. 16.
    United States Preventive Services Task Force (2002) Screening for lipid disorders in adults: recommendations and rationale. Internet J Intern Med 3(2). http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijim/vol3n2/lipid.xml. Accessed 8 Sept 2010
  17. 17.
    Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S (2008) Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 371:915–922CrossRefGoogle Scholar
  18. 18.
    Cheng J, Zhao D, Zeng Z, Critchley JA, Liu J, Wang W, Sun J, Capewell S (2009) The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing (1999–2010). BMC Public Health 9:30CrossRefGoogle Scholar
  19. 19.
    Gupta R, Kaul V, Bhagat N, Agrawal M, Gupta VP, Misra A, Vikram NK (2008) Trends in prevalence of coronary risk factors in an urban Indian population: Jaipur Heart Watch-4. Indian Heart J 156:112–119Google Scholar
  20. 20.
    Ghandehari H, Kamal-Bahl S, Wong ND (2008) Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003–2004. Am Heart J 156:112–119CrossRefGoogle Scholar
  21. 21.
    Lemieux I, Lamarche B, Couillard C, Pascot A, Cantin B, Bergeron J, Dagenais GR, Despres JP (2001) Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men. Arch Intern Med 161:2685–2692CrossRefGoogle Scholar
  22. 22.
    Bersot TP, Pépin GM, Mahley RW (2003) Risk determination in populations characterised by low levels of high-density lipoprotein cholesterol. Am Heart J 146:1052–1060CrossRefGoogle Scholar
  23. 23.
    Natarajan S, Glick H, Criqui M, Horowitz D, Lipsitz SR, Kinosian B (2003) Cholesterol measures to identify and treat individuals at risk for coronary heart disease. Am J Prev Med 25:50–57CrossRefGoogle Scholar
  24. 24.
    Centers for Disease Control. Heart Disease (On line). Available at http://www.cdc.gov/Features/WorldHeartDay/. Accessed 30 Sept 2010

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  1. 1.Huddleshield Royal InfirmaryLeedsUK
  2. 2.Department of MedicineUniversity of MauritiusRéduitMauritius

Personalised recommendations